Paul Hastings, a leading global law firm, announced today that the firm represented Novella Clinical, a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors, in its agreement merge with Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services.
The terms of the transaction were not disclosed and the transaction is subject to customary closing conditions.
Healthcare transaction counsel W. Craig Smith led the Paul Hastings team, which also included Antitrust and Competition partner C. Scott Hataway, Tax partner Philip Marzetti, Benefits partner Eric Keller, Employment partner C. Geoffrey Weirich and corporate associate Brian Teras.
